NASDAQ · Financial Statements

MedTech Acquisition Corporation (MTAC) Financial Statements

$11.34 NASDAQ: MTAC Market Cap $83.86M

MedTech Acquisition Corporation most recently reported annual revenue of $45.0M, a net loss of $70.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20202021202220242025
Revenue—$0$0$29.0M$45.0M
Operating Profit—$-3.0M$-3.0M$-36.0M$-27.0M
Net Profit—$5.0M$6.0M$-33.0M$-70.0M
EPS—$0.15$0.18$-1.06$-1.84
Op Margin———-122.9%-59.7%

Balance Sheet (USD)

Metric20202021202220242025
Total Assets$252.0M$251.0M$20.0M$65.0M$35.0M
Total Liabilities$9.0M$17.0M$14.0M$0$69.0M
Cash$1.0M$0$0$0$20.0M
Borrowings$0$1.0M$2.0M$0$34.0M

Cash Flow (USD)

Metric20202021202220242025
Operating Cash Flow—$-2.0M$-3.0M$-41.0M$-18.0M
Investing Cash Flow—$0$233.0M$0$-2.0M
Financing Cash Flow—$1.0M$-463.0M$38.0M$31.0M
Net Cash Flow—$-1.0M$0$-3.0M$12.0M
Free Cash Flow$0$-2.0M$-3.0M$-41.0M$-19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA-6.93
FCF Yield-27.76%
Quick Ratio4.97
Interest Coverage-13.00
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksNasdaq High ROE StocksAll stock screens
MTAC Overview MTAC Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.